NK cells patrol the body and, upon detecting cancerous or virus-infected cells, attack and eliminate them with strong cytotoxicity. Activated NK cells can recognize and attack cancer cells with ~60% efficiency.
NK-cell therapy expands and activates one’s own NK cells before reinfusion. Because autologous cells are used, serious side effects such as rejection or allergies are rare, making it suitable even for older adults.